02.09.2015 • NewsDede WillamsBayerCovestro

Bayer MaterialScience now Covestro

On Sept. 1, Bayer MaterialScience (BMS) began trading as Covestro. For the present, the new standalone company will remain wholly owned by Bayer, but the parent company’s plans foresee a stock flotation by mid-2016.

“Independence will enable us to bring our strengths to bear in global competition more quickly, effectively and flexibly,” said Covestro CEO Patrick Thomas, who has headed the business since 2007.

The newly independent company has not yet revealed whether it plans any consolidation or expansion of its portfolio. As BMS it recently took a step downstream with the takeover of TCG, a manufacturer of polycarbonate composites, primarily for the automotive, transport and IT industries.

Covestro is the world’s largest producer of polycarbonate and a leading player in the markets for most of its polyurethane products, which include isocyanates MDI and TDI, along with PU systems.

The engineering plastics producer is run by a four-member board of management chaired by Thomas. Other members include Frank H. Lutz (Finance, Labor Director), Dr. Klaus Schaefer (Production and Technology) and Dr. Markus Steilemann (Innovation).

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.